A sprinter’s marathon
Yellowjacket athlete Laura Lockard ’17 returned this spring for her final season as a key member of the track and field team. A fateful discovery during a voluntary study nearly knocked her off her stride, but Lockard, a microbiology major from Sayre, Pennsylvania, was determined to “make the best of everything” in her life.
Eastman musicians win DownBeat student awards
The Eastman New Jazz Ensemble and Eastman School of Music students Theresa Chen, George Darrah, and Jon Rarick have received DownBeat honors in the magazine’s 40th annual Student Awards competition.
Owen Broder selected as inaugural Eastman/ArtistShare New Artist
The saxophonist/composer is the first new artist to be announced under the partnership, designed to recognize and support the career and artistic development of exceptional Eastman students and alumni.
Gene may hold key to hearing recovery
Medical Center researchers have discovered that a protein implicated in human longevity may also play a role in restoring hearing after noise exposure.
2017-18 Eastman Presents concert lineup announced
The fourth annual Eastman Presents Concert Series will feature Chick Corea and Steve Gadd, the Accademia Nazionale di Santa Cecilia, Marian McPartland, Patti LuPone and more.
First worldwide trial tests defibrillators in diabetes patients
Individuals with diabetes have a high incidence of heart problems. A Medical Center study will determine if implantable defibrillators increase survival in this growing group of patients.
Medical Center plays key role in new Huntington’s drug
Medical Center researchers were instrumental in the U.S. Food and Drug Administration’s recent approval of SD-809 (deutetrabenazine) to treat Huntington’s disease.
Strong earns ‘Leader in LGBTQ Healthcare Equality’ designation
Strong Memorial Hospital earned a perfect score on the annual survey conducted by the Human Rights Campaign Foundation. The survey evaluates inclusive policies and practices related to LGBTQ patients, visitors, and health care employees.
FDA approves new eczema drug tested at URMC
The new drug, Dupilumab, is the first treatment to show significant, lasting results for adults with eczema. The FDA approval is a “game-changer,” says Lisa Beck, professor of dermatology who led three years of clinical trials.
Partnership will help create ‘eyes and ears’ for photonics technologies
A new Defense Department project will help researchers develop sensors for photonics-based systems with applications in environmental monitoring, disease diagnosis, and detection of chemical and biological weapons.